Colon and Rectal Cancer Survival by Tumor Location and Microsatellite Instability: The Colon Cancer Family Registry

BACKGROUND: Cancers in the proximal colon, distal colon, and rectum are frequently studied together; however, there are biological differences in cancers across these sites, particularly in the prevalence of microsatellite instability. OBJECTIVE: We assessed the differences in survival by colon or rectal cancer site, considering the contribution of microsatellite instability to such differences. DESIGN: This is a population-based prospective cohort study for cancer survival. SETTINGS: This study was conducted within the Colon Cancer Family Registry, an international consortium. Participants were identified from population-based cancer registries in the United States, Canada, and Australia. PATIENTS: Information on tumor site, microsatellite instability, and survival after diagnosis was available for 3284 men and women diagnosed with incident invasive colon or rectal cancer between 1997 and 2002, with ages at diagnosis ranging from 18 to 74. MAIN OUTCOME MEASURES: Cox regression was used to calculate hazard ratios for the association between all-cause mortality and tumor location, overall and by microsatellite instability status. RESULTS: Distal colon (HR, 0.59; 95% CI, 0.49–0.71) and rectal cancers (HR, 0.68; 95% CI, 0.57–0.81) were associated with lower mortality than proximal colon cancer overall. Compared specifically with patients with proximal colon cancer exhibiting no/low microsatellite instability, patients with distal colon and rectal cancers experienced lower mortality, regardless of microsatellite instability status; patients with proximal colon cancer exhibiting high microsatellite instability had the lowest mortality. LIMITATIONS: Study limitations include the absence of stage at diagnosis and cause-of-death information for all but a subset of study participants. Some patient groups defined jointly by tumor site and microsatellite instability status are subject to small numbers. CONCLUSION: Proximal colon cancer survival differs from survival for distal colon and rectal cancer in a manner apparently dependent on microsatellite instability status. These findings support the premise that proximal colon, distal colon, and rectal cancers are clinicopathologically distinct.

[1]  P. Allen.  ICDO — International Classification of Diseases for Oncology , 1991 .

[2]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[3]  P. Vihko,et al.  Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. , 1999, European journal of cancer.

[4]  Daniel J Sargent,et al.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Potter,et al.  Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. , 2003, Journal of the National Cancer Institute.

[6]  J. Cerhan,et al.  Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  G. Launoy,et al.  Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study) , 2004, Gut.

[8]  W. Willett,et al.  Comparison of risk factors for colon and rectal cancer , 2004, International journal of cancer.

[9]  A. Folsom,et al.  Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[10]  D. Sargent,et al.  Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. , 2006, Gastroenterology.

[11]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  Norman Wolmark,et al.  Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Goldbohm,et al.  Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites , 2008, International journal of cancer.

[14]  V. Stigliano,et al.  Journal of Experimental & Clinical Cancer Research Survival of Hereditary Non-polyposis Colorectal Cancer Patients Compared with Sporadic Colorectal Cancer Patients , 2008 .

[15]  S. Kakar,et al.  Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. , 2008, European journal of cancer.

[16]  S. Ogino,et al.  Molecular classification and correlates in colorectal cancer. , 2008, The Journal of molecular diagnostics : JMD.

[17]  N. Ahuja,et al.  Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers? , 2008, Annals of Surgical Oncology.

[18]  J. Zell,et al.  Tumor Subsite Location Within the Colon Is Prognostic for Survival After Colon Cancer Diagnosis , 2009, Diseases of the colon and rectum.

[19]  G. Casey,et al.  Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer , 2009, The British journal of surgery.

[20]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[21]  R. Palmqvist,et al.  The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening Status , 2010, Clinical Cancer Research.

[22]  L. Terracciano,et al.  Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. , 2010, International journal of oncology.

[23]  E. Dogliotti,et al.  Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. , 2010, European journal of cancer.

[24]  H. Brenner,et al.  Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. , 2010, Journal of the National Cancer Institute.

[25]  K. Hemminki,et al.  Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes , 2010, BMC Cancer.

[26]  J. Bond,et al.  Is BRAF Mutation Associated with Interval Colorectal Cancers? , 2010, Digestive Diseases and Sciences.

[27]  Cancer,et al.  Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial , 2010, The Lancet.

[28]  Rinku Sutradhar,et al.  Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. , 2011, Gastroenterology.

[29]  J. Hopper,et al.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. , 2011, The Journal of molecular diagnostics : JMD.

[30]  John D Potter,et al.  BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[31]  Levi Waldron,et al.  Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum , 2012, Gut.